Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out how to Use Your Brain research Degree in the Gig Market - 27 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide
- 3Careful Nurturing: Techniques for Bringing up Tough Children
- 4Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
- 5Unsold Rams May Be Less expensive Than You Suspect
- Find the Lively Food Markets of South America
- Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers
- What are the health benefits of whole milk for kids?
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- Smoking rate among US adults drops to record low as vape use rises, CDC report finds
- Israel reports killing another senior Iranian oil official
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- Mississippi Insight for Jan. 11, 2026
- Vote in favor of Your Number one BWM Vehicles
